Annovis Bio Inc (NYSE:ANVS)
$ 5.94 -0.09 (-1.49%) Market Cap: 66.36 Mil Enterprise Value: 63.22 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 38/100

Annovis Bio Inc Investor Webinar and Q&A with CEO Transcript

Apr 14, 2020 / 08:05PM GMT
Release Date Price: $3.1 (+5.80%)
Maria L. MacCecchini
Annovis Bio, Inc. - Founder, CEO, President & Director

Thank you for being with me today, and thank you so much for listening to our technology on how we do treat Alzheimer's and Parkinson's disease by protecting nerve cells from dying. I'm the Founder of Annovis Bio. I'm also the President and CEO, and I've been running this company for 10 years.

Since I'm a scientist, I spend most of my time to think about life, trying to figure out how nerve cells die and how we could prevent them from dying. And in fact, I'm here to tell you that we've figured it out. What happens when a nerve cell gets injured is that toxic proteins attack its information highway. And when the information highway in the nerve cell doesn't work, the nerve cell cannot talk to itself, it cannot talk to other nerve cells, it cannot talk to the body, it cannot talk to the environment. It gets isolated and sick and it dies. And our drug protects the nerve cell from all these things and does put the brain back into a healthy environment.

We went public in January. Our symbol is ANVS, and we are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot